Skip to main content
Canna~Fangled Abstracts

Prospective affirmative therapeutics of cannabidiol oil mitigates doxorubicin-induced abnormalities in kidney function, inflammation, and renal tissue changes

By November 16, 2023December 10th, 2023No Comments

doi: 10.1007/s00210-023-02836-4.

Online ahead of print.
Affiliations 

Abstract

Nephropathy is the decline in kidney function. A promising treatment for numerous types of illness is using natural materials as natural chemical compounds. The inquiry was conducted to investigate cannabidiol (CBD) potential for renal syndrome protection. The five equal groups of fifty male Sprague-Dawley rats weighing 150 ± 25 g each were designed; group I received distilled water orally, while group II got an intraperitoneal injection of doxorubicin (18 mg/kg bwt). Group III received CBD (26 mg/kg bwt) orally, while group IV received 1 ml of CBD (26 mg/kg bwt) and group V received trimetazidine (10 mg/kg bwt), in addition to a single intraperitoneal dose of doxorubicin (18 mg/kg bwt) on the 11th day for both groups (IV, V). The administration of CBD (26 mg/kg bwt) led to a noticeable improvement in oxidative stress parameters (SOD and GSH) in rats by significantly lowering enzyme activity (ALT and AST), as well as serum creatinine and urea, IL-6, and MDA, confirming the anti-inflammatory accuracy of CBD linked to significant lowering to IL6R DNA frequency concentration in line with histopathology results. As a result of its anti-inflammatory and antioxidant capabilities, cannabidiol may have protective quality, and CBD medication could be related to controlling renal problems.

Keywords: Cannabidiol, DNA, Doxorubicin, IL-6, Inflammation, Nephropathy

PubMed Disclaimer

References

    1. Afsar T, Razak S, Almajwal A, Al-Disi D (2020) Doxorubicin-induced alterations in kidney functioning, oxidative stress, DNA damage, and renal tissue morphology; improvement by Acacia hydaspica tannin-rich ethyl acetate fraction. Saudi J Biol Sci 27(9):2251–2260. https://doi.org/10.1016/j.sjbs.2020.07.011 – DOI – PubMed – PMC
    1. AlAsmari AF, Ali N, Alharbi M, Alqahtani F, Alasmari F, Almoqbel D, AlSwayyed M, Alshammari A, Alanazi MM, Alhoshani A, Al-Harbi NO (2022) Geraniol ameliorates doxorubicin-mediated kidney injury through alteration of antioxidant status, inflammation, and apoptosis: potential roles of NF-κB and Nrf2/Ho-1. Nutrients 14(8):1620. https://doi.org/10.3390/nu14081620 – DOI – PubMed – PMC
    1. Alherz FA, El-Masry TA, Negm WA, El-Kadem AH (2022) Potential cardioprotective effects of amentoflavone in doxorubicin-induced cardiotoxicity in mice. Biomed Pharmacother 154:113643. https://doi.org/10.1016/j.biopha.2022.113643
    1. Alherz FA, Negm WA, El-Masry TA, Elmorshedy KE, El-Kadem AH (2023) The potential beneficial role of ginkgetin in doxorubicin-induced hepatotoxicity: elucidating the underlying claim. Biomed Pharmacother 165:115010. https://doi.org/10.1016/j.biopha.2023.115010
    1. Ali N, Rashid S, Nafees S, Hasan SK, Shahid A, Majed F, Sultana S (2017) Protective effect of chlorogenic acid against methotrexate induced oxidative stress, inflammation and apoptosis in rat liver: an experimental approach. Chem Biol Interact 272:80–91. https://doi.org/10.1016/j.cbi.2017.05.002 – DOI – PubMed

LinkOut – more resources


Leave a Reply